Optinosis Information

Optinosis helps risk-bearing payers and providers save millions of dollars annually by reducing the total cost of care associated with late-stage cancer treatments. Our software identifies patients who are 95+% likely to have currently undiagnosed cancer, enabling more effective screening, much earlier diagnosis and less costly treatments. The solution analyzes existing claims data, allowing potential customers to quickly confirm its accuracy in a no-cost proof of concept.